{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:35:50Z","timestamp":1793223350863,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160636"],"award-info":[{"award-number":["82160636"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Key Laboratory of AIDS Prevention Control and Translation","award":["ZZH2020010"],"award-info":[{"award-number":["ZZH2020010"]}]},{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response"},{"name":"Guangxi Bagui Honor Scholarship"},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["AB22035027"],"award-info":[{"award-number":["AB22035027"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Health and Family Planning Commission Self-Financing Research Program","award":["Z-A20220358"],"award-info":[{"award-number":["Z-A20220358"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the profiles and determinants of drug resistance in HIV-1-infected individuals undergoing ART in Guangxi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Samples and data were collected from HIV-1-infected individuals experiencing virological failure post-ART from 14 cities in Guangxi. Sequencing of the HIV-1 pol gene was conducted, followed by analysis for drug resistance mutations using the Stanford University HIV Drug Resistance Database. Logistic regression was employed to identify potential risk factors associated with both HIV drug resistance and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 8963 individuals with pol sequences were included in this study. The overall prevalence of HIV-1 drug resistance (HIVDR) was 42.43% (3808\/8963), showing a decrease from 59.62% to 41.40% from 2016 to 2023. Factors such as being aged \u226550\u2005years, male, Han nationality, lower education levels, occupations including workers, peasants and children, AIDS, pre-treatment CD4 T cell counts &amp;lt;200\u2005cells\/mm3, infection with CRF01_AE and CRF55_01B subtypes, and ART regimen lamivudine\/zidovudine\/nevirapine were associated with higher susceptibility to HIVDR. The common mutations were M184V (17.38%) and K103N (22.14%). Additionally, the prevalence of M184V, S68G, M41L and G190A were different between the Han and Zhuang populations. Factors including age, gender, ethnicity, education level, occupation, infectious route, clinical stage, viral load, subtype, ART regimen and HIVDR showed significant associations with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The factors contributing to drug resistance in the HIV-1 ART individuals in Guangxi appear to be notably intricate. Continuous reinforcement of drug resistance surveillance is imperative, accompanied by the optimization of ART regimens to mitigate virological failures effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkae084","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T03:39:37Z","timestamp":1710214777000},"page":"1142-1152","source":"Crossref","is-referenced-by-count":12,"title":["Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China"],"prefix":"10.1093","volume":"79","author":[{"given":"Xianwu","family":"Pang","sequence":"first","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailing","family":"Tang","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningye","family":"Fang","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Xie","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Lan","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujia","family":"Liang","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Key Laboratory of AIDS Prevention Control and Translation, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention , Nanning, Guangxi , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2024050202513240200_dkae084-B1","author":"Chinese Center for Disease Control and Prevention"},{"key":"2024050202513240200_dkae084-B2","author":"National Health and Family Planning Commission of the People\u2019s Republic of China"},{"key":"2024050202513240200_dkae084-B3","author":"China Ministry of Health"},{"key":"2024050202513240200_dkae084-B4","author":"World Bank"},{"key":"2024050202513240200_dkae084-B5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(07)60315-8","article-title":"Evolution of China\u2019s response to HIV\/AIDS","volume":"369","author":"Wu","year":"2007","journal-title":"Lancet"},{"key":"2024050202513240200_dkae084-B6","author":"The Peoples Government of Guangxi Zhuang Autonomous Region"},{"key":"2024050202513240200_dkae084-B7","first-page":"5","article-title":"Progress towards the 90-90-90 targets for controlling HIV\u2014China, 2018","volume":"1","author":"Zhao","year":"2019","journal-title":"China CDC Wkly"},{"key":"2024050202513240200_dkae084-B8","doi-asserted-by":"crossref","first-page":"100238","DOI":"10.1016\/j.eclinm.2019.100238","article-title":"Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001-2017)","volume":"18","author":"Zuo","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2024050202513240200_dkae084-B9","author":"UNAIDS"},{"key":"2024050202513240200_dkae084-B10","doi-asserted-by":"crossref","first-page":"e0166661","DOI":"10.1371\/journal.pone.0166661","article-title":"Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China","volume":"11","author":"Zuo","year":"2016","journal-title":"PLoS One"},{"key":"2024050202513240200_dkae084-B11","doi-asserted-by":"crossref","first-page":"e72630","DOI":"10.1371\/journal.pone.0072630","article-title":"Prevalence and mutation patterns of HIV drug resistance from 2010 to 2011 among ART-failure individuals in the Yunnan province, China","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"2024050202513240200_dkae084-B12","first-page":"5894124","article-title":"HIV-1 drug resistance, distribution of subtypes, and drug resistance-associated mutations in virologic failure individuals in Chengdu, southwest China, 2014\u20132016","volume":"2020","author":"Chen","year":"2020","journal-title":"Biomed Res Int"},{"key":"2024050202513240200_dkae084-B13","first-page":"950","article-title":"Analysis of HIV-1 drug resistance among 1 922 individuals experiencing virological failure of first-line antiretroviral therapy in Henan province","volume":"49","author":"Liu","year":"2015","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"2024050202513240200_dkae084-B14","doi-asserted-by":"crossref","first-page":"e0165110","DOI":"10.1371\/journal.pone.0165110","article-title":"An analysis of drug resistance among people living with HIV\/AIDS in Shanghai, China","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"2024050202513240200_dkae084-B15","doi-asserted-by":"crossref","first-page":"B39","DOI":"10.1016\/j.vaccine.2009.07.101","article-title":"Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in east Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies","volume":"28","author":"Takebe","year":"2010","journal-title":"Vaccine"},{"key":"2024050202513240200_dkae084-B16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/09540121003615129","article-title":"Progress of the national pediatric free antiretroviral therapy program in China","volume":"22","author":"Zhao","year":"2010","journal-title":"AIDS Care"},{"key":"2024050202513240200_dkae084-B17","first-page":"315","article-title":"[Epidemiological characteristics of HIV\/AIDS in Guangxi Zhuang autonomous region, 2010-2017]","volume":"40","author":"Ge","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2024050202513240200_dkae084-B18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12879-020-05124-1","article-title":"Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study","volume":"20","author":"Yuan","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2024050202513240200_dkae084-B19","first-page":"800","article-title":"HIV-1 subtype diversity and factors affecting drug resistance among patients with virologic failure in antiretroviral therapy in Hainan province, China, 2014\u20132020","volume":"36","author":"Yu","year":"2023","journal-title":"Biomed Environ Sci"},{"key":"2024050202513240200_dkae084-B20","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection","volume":"358","author":"Riddler","year":"2008","journal-title":"N Engl J Med"},{"key":"2024050202513240200_dkae084-B21","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMoa031772","article-title":"Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection","volume":"350","author":"Gulick","year":"2004","journal-title":"N Engl J Med"},{"key":"2024050202513240200_dkae084-B22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/jmbi.2001.4648","article-title":"The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance","volume":"309","author":"Hsiou","year":"2001","journal-title":"J Mol Biol"},{"key":"2024050202513240200_dkae084-B23","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.44.9.2475-2484.2000","article-title":"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy","volume":"44","author":"Bacheler","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2024050202513240200_dkae084-B24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jama.1996.03540020040027","article-title":"Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group","volume":"276","author":"Katlama","year":"1996","journal-title":"JAMA"},{"key":"2024050202513240200_dkae084-B25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3851\/IMP2266","article-title":"Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003\u20132010","volume":"17","author":"Miller","year":"2012","journal-title":"Antivir Ther"},{"key":"2024050202513240200_dkae084-B26","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/JVI.74.14.6262-6268.2000","article-title":"Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection","volume":"74","author":"Frost","year":"2000","journal-title":"J Virol"},{"key":"2024050202513240200_dkae084-B27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/171.6.1411","article-title":"Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)","volume":"171","author":"Schuurman","year":"1995","journal-title":"J Infect Dis"},{"key":"2024050202513240200_dkae084-B28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"TenoRes Study Group","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2024050202513240200_dkae084-B29","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1097\/QAD.0000000000003082","article-title":"Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era","volume":"35","author":"McCluskey","year":"2021","journal-title":"AIDS"},{"key":"2024050202513240200_dkae084-B30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"GBD DALYs","year":"2016","journal-title":"Lancet"},{"key":"2024050202513240200_dkae084-B31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med"},{"key":"2024050202513240200_dkae084-B32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e32835e163d","article-title":"Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV","volume":"27","author":"Jansson","year":"2013","journal-title":"AIDS"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/5\/1142\/57368178\/dkae084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/5\/1142\/57368178\/dkae084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T22:53:17Z","timestamp":1714603997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/5\/1142\/7637419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,29]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae084","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,3,29]]}}}